<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">NSS</journal-id>
      <journal-id journal-id-type="pmc">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">31824198</article-id>
      <article-id pub-id-type="pmc">6901050</article-id>
      <article-id pub-id-type="publisher-id">226143</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S226143</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Nocturnal Mean Oxygen Saturation Is Associated with Secondary Polycythemia in Young Adults with Obstructive Sleep Apnea, Especially in Men</article-title>
        <alt-title alt-title-type="running-authors">Li et al</alt-title>
        <alt-title alt-title-type="running-title">Li et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Li</surname>
            <given-names>Ning</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001">1</xref>
          <xref ref-type="aff" rid="AFF0002">2</xref>
          <xref ref-type="author-notes" rid="FT0001"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Li</surname>
            <given-names>Hong Peng</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001">1</xref>
          <xref ref-type="aff" rid="AFF0002">2</xref>
          <xref ref-type="author-notes" rid="FT0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Ping</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001">1</xref>
          <xref ref-type="aff" rid="AFF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yan</surname>
            <given-names>Ya Ru</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001">1</xref>
          <xref ref-type="aff" rid="AFF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Shi Qi</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001">1</xref>
          <xref ref-type="aff" rid="AFF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Qing Yun</given-names>
          </name>
          <xref ref-type="corresp" rid="AN0001"/>
          <xref ref-type="aff" rid="AFF0001">1</xref>
          <xref ref-type="aff" rid="AFF0002">2</xref>
        </contrib>
        <aff id="AFF0001"><label>1</label><institution>Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="AFF0002"><label>2</label><institution>Institute of Respiratory Disease, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>People’s Republic of China</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="AN0001">Correspondence: Qing Yun Li <institution>Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>No. 197 Ruijin 2nd Road</addr-line>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country>People’s Republic of China</country><phone>Tel +86-21-64370045</phone><fax>Fax +86-21-57643271</fax> Email liqingyun68@hotmail.com</corresp>
        <fn id="FT0001">
          <label>*</label>
          <p><citation_analysis attribute="neither">These authors contributed equally to this work</citation_analysis></p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>12</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2019</year>
      </pub-date>
      <volume>11</volume>
      <fpage>377</fpage>
      <lpage>386</lpage>
      <history>
        <date date-type="received">
          <day>06</day>
          <month>8</month>
          <year>2019</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>11</month>
          <year>2019</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2019 Li et al.</copyright-statement>
        <copyright-year>2019</copyright-year>
        <copyright-holder>Li et al.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="S2001">
          <title>Objective</title>
          <p><citation_analysis attribute="neither">Whether the severity of obstructive sleep apnea (OSA) contributes to clinical polycythemia is uncertain, especially in young adults. This study aimed to assess the correlation between untreated OSA and polycythemia, controlling for multiple confounders, and to observe the difference in both genders.</citation_analysis></p>
        </sec>
        <sec id="S2002">
          <title>Methods</title>
          <p><citation_analysis attribute="neither">All participants underwent nocturnal polysomnography. Medical comorbidities, and demographic and laboratory information were also recorded. The relationship between OSA and concomitant polycythemia in both genders was analyzed.</citation_analysis></p>
        </sec>
        <sec id="S2003">
          <title>Results</title>
          <p><citation_analysis attribute="neither">A total of 605 young participants (383 men and 222 women), aged 30.52 ± 7.21 years, were enrolled, with an average body mass index of 32.48 ± 6.06 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither">. Although 74.4% of patients were diagnosed with OSA, less than 10% had polycythemia. The levels of hemoglobin and hematocrit increased with the severity of OSA; only men with severe OSA had significantly higher hemoglobin, hematocrit, and polycythemia compared with those in the control group (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01). Hemoglobin and hematocrit significantly correlated with mean pulse oxygen saturation (SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">) (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), but the correlation coefficients were weaker in women than in men. In logistic regression analysis, mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, but not the apnea–hypopnea index (AHI), was found to be an independent predictor of polycythemia (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05). Areas under the receive operator characteristic analysis revealed that the cutoff values of hemoglobin and hematocrit were 155.5g/L and 44.6% (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), respectively, for assessing nocturnal hypoxemia in men with OSA.</citation_analysis></p>
        </sec>
        <sec id="S2004">
          <title>Conclusion</title>
          <p><citation_analysis attribute="neither">Nocturnal mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> was an independent predictor of polycythemia in young adults. Mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, compared with the AHI, was more associated with polycythemia. Men were more prone to suffer from polycythemia compared with women. Hemoglobin and hematocrit values might have diagnostic utility for assessing nocturnal hypoxia severity of OSA patients, especially in men.</citation_analysis></p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>obstructive sleep apnea</kwd>
        <kwd>nocturnal hypoxia</kwd>
        <kwd>polycythemia</kwd>
        <kwd>erythropoiesis</kwd>
        <kwd>biomarker</kwd>
      </kwd-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="5"/>
        <ref-count count="38"/>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Obstructive sleep apnea (OSA) is a common disease. Almost one billion people worldwide have OSA, with China having the highest number of affected persons, followed by the United States, Brazil, and India.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> Polycythemia is defined as an absolute increase in hemoglobin (HGB) or hematocrit (HCT).</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> It is classified as primary (e.g., polycythemia vera) or secondary [such as chronic continuous hypoxia (CCH) and renal lesions]. It results in increased circulating levels of erythropoiesis-stimulating factors. Although OSA is characterized by chronic intermittent hypoxia (CIH),</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> rather than sustained hypoxemia, it was assumed that the intermittent hypoxic stress was sufficient to produce secondary polycythemia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither"> Fan et al found that HGB and HCT significantly correlated with the apnea-hypopnea index (AHI) among 1087 male patients, and HCT might be a predictor of OSA severity.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> Relevant meta-analyses provided the same point of view.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither"> Several animal studies also indicated that red blood cell (RBC) count, HGB, and HCT were much higher after exposure to intermittent hypoxia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="positive"> After continuous positive airway pressure (CPAP) therapy, RBC count, HGB, and HCT declined in patients with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="positive"> Moreover, Pathak et al analyzed more than 77 million discharges and showed a significant association between OSA and secondary polycythemia with an odds ratio (OR) of 5.90 [95% confidence interval (CI): 5.64–6.17].</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> Therefore, OSA is mentioned as a cause of secondary polycythemia in the current national guidelines on the diagnosis, investigation, and management.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither"> However, other studies pointed out that intermittent nocturnal hypoxemia in OSA did not lead to clinical polycythemia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="positive"> King et al considered that secondary polycythemia in patients with OSA was caused by a reduction in plasma volume rather than hypoxia and a recent study evaluating this association (n = 1604 participants) reported no significant differences in HGB or HCT among patients with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> Therefore, whether OSA severity contributes to clinical polycythemia remains controversial.</citation_analysis></p>
      <p><citation_analysis attribute="neither">A wide variety of factors, including race, age, sex, altitude, and smoking, affect the values of hematological indices.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither"> Disparate genetic backgrounds are found among ethnic groups.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> For example, African Americans have slightly lower HBG and HCT compared with Caucasians,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither"> and people living at high altitudes develop higher HCT to compensate for low oxygen exposure.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither"> The differences in hematological profiles between men and women are also well known.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> The values of RBC count, HGB, and HCT increased until adulthood, which were higher in men than in women at all ages,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> and then decreased in the geriatric age.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither"> People aged more than 50 years were more prone to suffer from anemia of aging.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="positive"> Previous studies generally evaluated predominantly elderly male subjects and failed to define polycythemia well.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> The extent to which untreated OSA contributes to clinical polycythemia among young Asian adults remains uncertain.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither"> Furthermore, OSA is a heterogeneous disorder,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="positive"> hypoxia indicates significant differences in OSA patients within similar AHI.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="negative"> The cutoff point of hematological indices determining an individual’s nocturnal hypoxia risk of OSA was unclear.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="positive"> This study aimed to evaluate the association between untreated OSA and polycythemia in a relatively large young sample taking into account established confounders. Moreover, the effects of gender-related differences and the cutoff value of hematological indices were also analyzed.</citation_analysis></p>
    </sec>
    <sec id="S0002">
      <title>Methods</title>
      <sec id="S0002-S2001">
        <title>Study Population</title>
        <p><citation_analysis attribute="neither">In this study, consecutive participants who underwent polysomnography (PSG) at the Sleep Disorders Center of Ruijin Hospital affiliated to Shanghai JiaoTong University from September 2009 to September 2017 were enrolled. The demographic characteristics, smoking status, and previous history of chronic diseases were recorded. The body mass index (BMI) was calculated as body weight (in kg) divided by body height (in m) squared. Hypertension was defined as a systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥ 90 mmHg, or a clinical diagnosis of hypertension and current prescription of antihypertensive medication.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither"> The smokers were those regularly consumed 10–20 cigarettes/day for at least 3 years.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither"> The inclusion criteria were as follows: 1) participants aged 18–45 years old; and 2) Han Chinese residents of Southeast China with altitude below 10 meters. The exclusion criteria were as follows: patients with sleep disorders other than OSA (e.g., central sleep apnea syndrome, restless leg syndrome, and narcolepsy), previous treatment for OSA (e.g., CPAP, surgery, and oral device), hematologic diseases (e.g., polycythemia vera, other causes of primary/secondary erythrocytosis, anemia, leukemia, and lymphoma), chronic cardiopulmonary diseases except for primary hypertension, liver or kidney disease, neuromuscular disease, malnutrition, chronic alcoholism, malignancy, pregnancy, acute and/or chronic infection, use of medication (such as erythropoietin iron, folate, vitamin B</citation_analysis><citation_analysis attribute="positive"><sub>12</sub></citation_analysis><citation_analysis attribute="positive">, and contraceptives), and living at high altitudes in the past. Postmenopausal women with an established diagnosis of polycystic ovary syndrome (PCOS) or suspected of having PCOS based on hyperandrogenemia were also excluded. The study was conducted in accordance with the Declaration of Helsinki and approved by the local ethics committee of Ruijin Hospital ([2018] No.107). Written informed consent was obtained from all participants.</citation_analysis></p>
      </sec>
      <sec id="S0002-S2002">
        <title>Polysomnographic Evaluation</title>
        <p><citation_analysis attribute="positive">All the participants underwent PSG (Alice 5, Philips Respironics, Pennsylvania, USA) at the laboratory with alcohol, caffeine, sedatives, or hypnotics forbidden on that very day. PSG channels included four electroencephalograms, submental electromyogram, two electrooculograms (right and left), two electrocardiography channels, pulse oxygen saturation, oral and nasal airflow, nasal air pressure, thoracic–abdominal respiratory movement, snoring microphone, and body position. Only edited records with more than 4 h of good-quality signals were accepted. Apnea was defined as a respiratory event with a drop in nasal airflow by ≥ 90%, and hypopnea was defined as a drop in peak signal excursions by ≥ 30% of pre-event baseline using nasal pressure for at least 10 seconds with a ≥ 4% oxygen desaturation from pre-event baseline. Based on the AHI, the participants were categorized into four groups: control (AHI &lt; 5), mild (AHI, 5–14.9), moderate (AHI, 15–29.9), and severe OSA (AHI ≥ 30) groups. The oxygen desaturation index (ODI) was defined as the total number of at least 4% oxygen desaturations per total sleep time in hours and the mean pulse oxygen saturation (SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">) was defined as the mean oxygen saturation during sleep periods at night. The percentage of sleep duration with SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> &lt; 90% (TS90) was also included.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0031" ref-type="bibr">31</xref></citation_analysis></p>
      </sec>
      <sec id="S0002-S2003">
        <title>Laboratory Measurements</title>
        <p><citation_analysis attribute="positive">Fasting blood samples were taken in the morning after PSG monitoring. Complete blood cell count was analyzed using as automated hematology analysis device (CELL-DYN Ruby, Abbott Laboratories, Illinois, USA). Polycythemia was defined as an HGB level of &gt; 160 g/L in women and &gt; 165 g/L in men, or an HCT level of &gt; 48% in women and &gt; 49% in men according to the World Health Organization thresholds.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> In this study, clinical polycythemia defined by HGB (polycythemia–HGB) and HCT (polycythemia–HCT) was described.</citation_analysis></p>
      </sec>
      <sec id="S0002-S2004">
        <title>Statistical Analysis</title>
        <p><citation_analysis attribute="positive">Data were analyzed using statistical software (IBM SPSS Statistics for Windows, version 25.0, USA). Continuous variables were reported as means ± standard deviations (SD), or median with an interquartile range if variables were not normally distributed. Categorical variables were reported as the constituent ratio (%). The significance of the mean differences between groups was assessed using the Student </citation_analysis><citation_analysis attribute="positive"><italic>t</italic></citation_analysis><citation_analysis attribute="neither">-test and one-way analysis of variance. For measurement data that were heteroscedastic or not normally distributed, the Mann–Whitney </citation_analysis><citation_analysis attribute="positive"><italic>U-</italic></citation_analysis><citation_analysis attribute="neither">test and Kruskal–Wallis </citation_analysis><citation_analysis attribute="positive"><italic>H</italic></citation_analysis><citation_analysis attribute="positive">-test were conducted for comparison among groups. The constituent ratio among the groups was compared using the chi-square test. Spearman correlation coefficients were used to quantify the correlations among RBC count, HGB, HCT, and PSG parameters. Ordinal multivariate logistic regression analysis was performed to determine whether polycythemia was independently related to OSA severity. The effect of various variables on polycythemia–HGB and polycythemia–HCT in women was analyzed with rare events logistic regression analysis using Stata SE version 15.0 (StataCorp, TX, USA). The receiver-operating characteristic (ROC) analysis was used to estimate the predictive validity of HGB and HCT in assessing nocturnal hypoxemia (mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> &lt; 90%) and OSA (AHI ≥ 5), and to determine the optimal cutoff value. According to the area under the curve (AUC), the diagnostic values of HGB and HCT were assessed: ≤ 0.5 was considered a chance result; 0.5–0.7, low accuracy; 0.7–0.9, moderate accuracy; and ≥ 0.9, high accuracy. A </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> value &lt;0.05 for a two-tailed test was considered statistically significant.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="S0003">
      <title>Results</title>
      <sec id="S0003-S2001">
        <title>Overall Characteristics of the Participants</title>
        <p><citation_analysis attribute="positive">In total, 605 participants were included in this study (383 men and 222 women) with an average age of 30.52 ± 7.21 years (range, 18–45 years). The baseline characteristics of the study population are presented in </citation_analysis><citation_analysis attribute="positive"><xref rid="T0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">. The mean BMI was 32.48 ± 6.07 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither">. No difference was observed between men and women in terms of BMI. Nearly one-quarter of men, but no women, were involved in active smoking. On average, the participants had severe OSA with a mean AHI of 19.70 (range, 0–109.3). Although 450 participants (74.4%) were diagnosed with OSA, only 8.0% (n = 36) had polycythemia–HGB and 5.3% (n = 24) had polycythemia–HCT. The mean HGB and HCT values were in the clinically normal range in both genders. AHI, ODI, TS90, RBC count, HBG, and HCT were significantly higher, while mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> was significantly lower among men compared with women. The occurrence of polycythemia increased in men than in women (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.005; </citation_analysis><citation_analysis attribute="positive"><xref rid="T0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap id="T0001" orientation="portrait" position="float"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Baseline Clinical, Laboratory, and Polysomnographic Data of All Participants</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variables</th><th rowspan="1" colspan="1">Total (n = 605)</th><th rowspan="1" colspan="1">Men (n = 383)</th><th rowspan="1" colspan="1">Women (n = 222)</th><th rowspan="1" colspan="1"><italic>P</italic> Value*</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (year)</td><td rowspan="1" colspan="1">30.52 ± 7.21</td><td rowspan="1" colspan="1">32.39 ± 7.19</td><td rowspan="1" colspan="1">27.30 ± 6.03</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">32.48 ± 6.07</td><td rowspan="1" colspan="1">32.21 ± 6.30</td><td rowspan="1" colspan="1">32.95 ± 5.62</td><td rowspan="1" colspan="1">0.148</td></tr><tr><td rowspan="1" colspan="1">Neck circumference (cm)</td><td rowspan="1" colspan="1">41.51 ± 4.01</td><td rowspan="1" colspan="1">42.40 ± 3.70</td><td rowspan="1" colspan="1">39.97 ± 4.06</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">AHI (events/h)</td><td rowspan="1" colspan="1">19.70 (4.70–57.75)</td><td rowspan="1" colspan="1">40.00 (11.80–67.60)</td><td rowspan="1" colspan="1">6.05 (1.38–16.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ODI (events/h)</td><td rowspan="1" colspan="1">26.30 (6.40–61.40)</td><td rowspan="1" colspan="1">43.05 (13.15–69.40)</td><td rowspan="1" colspan="1">8.10 (2.35–27.80)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Mean SpO<sub>2</sub> (%)</td><td rowspan="1" colspan="1">93.66 ± 4.45</td><td rowspan="1" colspan="1">92.78 ± 4.43</td><td rowspan="1" colspan="1">95.08 ± 4.12</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">TS90 (%)</td><td rowspan="1" colspan="1">2.30 (0.10–21.44)</td><td rowspan="1" colspan="1">7.95 (0.40–30.93)</td><td rowspan="1" colspan="1">0.10 (0.00–1.90)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">RBC count (10<sup>3</sup>/μL)</td><td rowspan="1" colspan="1">4.81 ± 0.47</td><td rowspan="1" colspan="1">5.00 ± 0.41</td><td rowspan="1" colspan="1">4.49 ± 0.40</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">HGB (g/L)</td><td rowspan="1" colspan="1">144.17 ± 14.00</td><td rowspan="1" colspan="1">150.92 ± 11.16</td><td rowspan="1" colspan="1">132.51 ± 10.23</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">HCT (%)</td><td rowspan="1" colspan="1">42.55 ± 3.95</td><td rowspan="1" colspan="1">44.42 ± 3.17</td><td rowspan="1" colspan="1">39.32 ± 2.94</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Polycythemia-HGB, n (%)</td><td rowspan="1" colspan="1">39 (6.45)</td><td rowspan="1" colspan="1">34 (8.88)</td><td rowspan="1" colspan="1">5 (2.25)</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">Polycythemia-HCT, n (%)</td><td rowspan="1" colspan="1">26 (4.30)</td><td rowspan="1" colspan="1">24 (6.27)</td><td rowspan="1" colspan="1">2 (0.90)</td><td rowspan="1" colspan="1">0.002</td></tr><tr><td rowspan="1" colspan="1">Smoking, n (%)</td><td rowspan="1" colspan="1">87 (14.38)</td><td rowspan="1" colspan="1">87 (22.72)</td><td rowspan="1" colspan="1">0 (0.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Hypertension, n (%)</td><td rowspan="1" colspan="1">134 (22.15)</td><td rowspan="1" colspan="1">118 (30.81)</td><td rowspan="1" colspan="1">16 (7.21)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn><p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Measurement data are presented as mean ± standard deviations or median with inter-quartile range if variables were not normally distributed. *Men vs women.</citation_analysis></p></fn><fn><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> BMI, body mass index; AHI, apnea–hypopnea index; ODI, oxygen desaturation index; Mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, mean oxygen saturation; TS90, percentage of sleep duration with SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> &lt; 90%; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="S0003-S2002">
        <title>Correlations Between OSA and Interrelated Parameters of RBC</title>
        <p><citation_analysis attribute="positive"><xref rid="T0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither"> provides a summary of demographic and clinical characteristics in male and female participants according to the OSA severity status.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="positive"> Patients with OSA were generally older and weighted, and more likely suffered from hypertension. The RBC count, HBG, and HCT increased with the severity of OSA in both genders. The male patients in the severe OSA group had significantly higher RBC count, HBG, and HCT compared with the other two groups (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01, </citation_analysis><citation_analysis attribute="positive"><xref rid="T0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="positive">), while no difference was found between the male participants in the control group and the mild-to-moderate OSA group. The female participants showed no statistical difference in RBC count, HBG, and HCT among the three groups with respect to OSA measured by the AHI. As shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="T0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">, HCT and HBG significantly correlated with all the PSG parameters related to OSA, such as AHI, ODI, TS90, and mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, in male participants. Although mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> negatively correlated with the RBC count, HGB, and HCT in women, the correlation coefficients were weaker than those in men. In addition, the AHI was not associated with HGB and HCT among female participants.</citation_analysis><citation_analysis attribute="positive"><table-wrap id="T0002" orientation="landscape" position="float"><label>Table 2</label><caption><p><citation_analysis attribute="neither">Baseline Clinical, Laboratory, and Polysomnographic Data of Male and Female Participants Stratified by OSA Severity Status</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="4" rowspan="1">Men</th><th colspan="4" rowspan="1">Women</th></tr><tr><th rowspan="1" colspan="1">Variables</th><th rowspan="1" colspan="1">Control (n = 53)</th><th rowspan="1" colspan="1">Mild-to-Moderate OSA (n = 110)</th><th rowspan="1" colspan="1">Severe OSA (n = 220)</th><th rowspan="1" colspan="1"><italic>P</italic> Value</th><th rowspan="1" colspan="1">Control (n = 102)</th><th rowspan="1" colspan="1">Mild-to-Moderate OSA (n = 88)</th><th rowspan="1" colspan="1">Severe OSA (n = 32)</th><th rowspan="1" colspan="1"><italic>P</italic> Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (year)</td><td rowspan="1" colspan="1">28.70 ± 7.55</td><td rowspan="1" colspan="1">29.86 ± 7.60</td><td rowspan="1" colspan="1">34.55 ± 6.06*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">25.94 ± 5.28</td><td rowspan="1" colspan="1">27.45 ± 5.88</td><td rowspan="1" colspan="1">31.19 ± 7.04*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">33.38 ± 5.08</td><td rowspan="1" colspan="1">32.85 ± 7.23</td><td rowspan="1" colspan="1">31.61 ± 6.02</td><td rowspan="1" colspan="1">0.084</td><td rowspan="1" colspan="1">31.81 ± 5.06</td><td rowspan="1" colspan="1">33.20 ± 5.27</td><td rowspan="1" colspan="1">35.90 ± 7.10*<sup>,†</sup></td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">Neck circumference (cm)</td><td rowspan="1" colspan="1">41.73 ± 2.52</td><td rowspan="1" colspan="1">42.49 ± 3.75</td><td rowspan="1" colspan="1">42.53 ± 3.92</td><td rowspan="1" colspan="1">0.368</td><td rowspan="1" colspan="1">39.00 ± 3.49</td><td rowspan="1" colspan="1">40.26 ± 4.15*</td><td rowspan="1" colspan="1">42.40 ± 4.59*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">AHI (events/h)</td><td rowspan="1" colspan="1">2.00 (0.95–3.15)</td><td rowspan="1" colspan="1">14.25 (8.60–22.43)*</td><td rowspan="1" colspan="1">64.70 (49.93–74.23)*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.30 (0.60–2.53)</td><td rowspan="1" colspan="1">11.05 (7.20–16.45)*</td><td rowspan="1" colspan="1">65.90 (46.53–85.98)*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ODI (events/h)</td><td rowspan="1" colspan="1">4.50 (1.65–10.40)</td><td rowspan="1" colspan="1">13.60 (7.10–26.80)*</td><td rowspan="1" colspan="1">65.55 (50.65–79.25)*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">3.20 (1.00–8.83)</td><td rowspan="1" colspan="1">10.60 (5.08–28.93)*</td><td rowspan="1" colspan="1">85.10 (52.40–110.50)*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Mean SpO<sub>2</sub> (%)</td><td rowspan="1" colspan="1">95.88 ± 1.45</td><td rowspan="1" colspan="1">95.26 ± 2.33</td><td rowspan="1" colspan="1">90.86 ± 4.66*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">96.39 ± 1.46</td><td rowspan="1" colspan="1">95.72 ± 1.70</td><td rowspan="1" colspan="1">88.90 ± 7.98*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">TS90 (%)</td><td rowspan="1" colspan="1">0.00 (0.00–0.35)</td><td rowspan="1" colspan="1">0.85 (0.10–3.70)*</td><td rowspan="1" colspan="1">24.50 (10.30–43.50)*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.00 (0.00–0.10)</td><td rowspan="1" colspan="1">0.30 (0.00–2.58)*</td><td rowspan="1" colspan="1">26.35 (4.30–45.30)*<sup>,†</sup></td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">RBC count (10<sup>3</sup>/μL)</td><td rowspan="1" colspan="1">4.91 ± 0.40</td><td rowspan="1" colspan="1">4.93 ± 0.38</td><td rowspan="1" colspan="1">5.05 ± 0.42*<sup>,†</sup></td><td rowspan="1" colspan="1">0.009</td><td rowspan="1" colspan="1">4.40 ± 0.31</td><td rowspan="1" colspan="1">4.54 ± 0.42*</td><td rowspan="1" colspan="1">4.64 ± 0.55*</td><td rowspan="1" colspan="1">0.004</td></tr><tr><td rowspan="1" colspan="1">HGB (g/L)</td><td rowspan="1" colspan="1">148.17 ± 10.66</td><td rowspan="1" colspan="1">148.92 ± 9.46</td><td rowspan="1" colspan="1">152.59 ± 11.79*<sup>,†</sup></td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">132.20 ± 9.16</td><td rowspan="1" colspan="1">132.60 ± 10.57</td><td rowspan="1" colspan="1">133.25 ± 12.55</td><td rowspan="1" colspan="1">0.874</td></tr><tr><td rowspan="1" colspan="1">HCT (%)</td><td rowspan="1" colspan="1">43.70 ± 3.09</td><td rowspan="1" colspan="1">43.77 ± 2.71</td><td rowspan="1" colspan="1">44.91 ± 3.32*<sup>,†</sup></td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1">39.08 ± 2.63</td><td rowspan="1" colspan="1">39.35 ± 2.67</td><td rowspan="1" colspan="1">39.98 ± 4.29</td><td rowspan="1" colspan="1">0.315</td></tr><tr><td rowspan="1" colspan="1">Polycythemia-HGB, n (%)</td><td rowspan="1" colspan="1">2 (3.77)</td><td rowspan="1" colspan="1">5 (4.55)</td><td rowspan="1" colspan="1">27 (12.27)<sup>†</sup></td><td rowspan="1" colspan="1">0.025</td><td rowspan="1" colspan="1">1 (0.98)</td><td rowspan="1" colspan="1">2 (2.27)</td><td rowspan="1" colspan="1">2 (6.25)</td><td rowspan="1" colspan="1">0.215</td></tr><tr><td rowspan="1" colspan="1">Polycythemia-HCT, n (%)</td><td rowspan="1" colspan="1">1 (1.89)</td><td rowspan="1" colspan="1">1 (0.91)</td><td rowspan="1" colspan="1">22 (10.00)<sup>†</sup></td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1">1 (0.98)</td><td rowspan="1" colspan="1">0 (0.00)</td><td rowspan="1" colspan="1">1 (3.13)</td><td rowspan="1" colspan="1">0.275</td></tr><tr><td rowspan="1" colspan="1">Smoking, n (%)</td><td rowspan="1" colspan="1">8 (15.09)</td><td rowspan="1" colspan="1">22 (20.00)</td><td rowspan="1" colspan="1">57 (25.91)</td><td rowspan="1" colspan="1">0.174</td><td rowspan="1" colspan="1">/</td><td rowspan="1" colspan="1">/</td><td rowspan="1" colspan="1">/</td><td rowspan="1" colspan="1">/</td></tr><tr><td rowspan="1" colspan="1">Hypertension, n (%)</td><td rowspan="1" colspan="1">9 (16.98)</td><td rowspan="1" colspan="1">28 (25.45)</td><td rowspan="1" colspan="1">69 (31.36)*</td><td rowspan="1" colspan="1">0.091</td><td rowspan="1" colspan="1">7 (6.86)</td><td rowspan="1" colspan="1">14 (15.91)*</td><td rowspan="1" colspan="1">7 (21.88)*</td><td rowspan="1" colspan="1">0.040</td></tr></tbody></table><table-wrap-foot><fn><p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Data are presented as mean ± standard deviations or median with inter-quartile range if variables were not normally distributed. *</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt;0.05 vs the control group; </citation_analysis><citation_analysis attribute="positive"><sup>†</sup></citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt;0.05 vs the mild-to-moderate OSA group.</citation_analysis></p></fn><fn><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> OSA, obstructive sleep apnea; BMI, body mass index; AHI, apnea–hypopnea index; ODI, oxygen desaturation index; Mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, mean oxygen saturation; TS90, percentage of sleep duration with SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">&lt; 90%; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><table-wrap id="T0003" orientation="portrait" position="float"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Correlations Between Polysomnographic Parameters and RBC Count, HGB, and HCT in Male and Female Participants</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="3" rowspan="1">Men</th><th colspan="3" rowspan="1">Women</th></tr><tr><th rowspan="1" colspan="1">Variables</th><th rowspan="1" colspan="1">RBC Counts</th><th rowspan="1" colspan="1">Hemoglobin</th><th rowspan="1" colspan="1">Hematocrit</th><th rowspan="1" colspan="1">RBC Counts</th><th rowspan="1" colspan="1">Hemoglobin</th><th rowspan="1" colspan="1">Hematocrit</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (year)</td><td rowspan="1" colspan="1">−0.068, 0.184</td><td rowspan="1" colspan="1">0.117, 0.022</td><td rowspan="1" colspan="1">0.023, 0.659</td><td rowspan="1" colspan="1">−0.048, 0.473</td><td rowspan="1" colspan="1">−0.045, 0.504</td><td rowspan="1" colspan="1">−0.068, 0.316</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">0.152, 0.003</td><td rowspan="1" colspan="1">−0.067, 0.194</td><td rowspan="1" colspan="1">0.019, 0.715</td><td rowspan="1" colspan="1">0.228, 0.001</td><td rowspan="1" colspan="1">0.007, 0.915</td><td rowspan="1" colspan="1">0.097, 0.150</td></tr><tr><td rowspan="1" colspan="1">AHI (events/h)</td><td rowspan="1" colspan="1">0.212, &lt;0.001</td><td rowspan="1" colspan="1">0.211, &lt;0.001</td><td rowspan="1" colspan="1">0.212, &lt;0.001</td><td rowspan="1" colspan="1">0.226, 0.001</td><td rowspan="1" colspan="1">0.028, 0.683</td><td rowspan="1" colspan="1">0.094, 0.164</td></tr><tr><td rowspan="1" colspan="1">ODI (events/h)</td><td rowspan="1" colspan="1">0.238, &lt;0.001</td><td rowspan="1" colspan="1">0.182, &lt;0.001</td><td rowspan="1" colspan="1">0.200, &lt;0.001</td><td rowspan="1" colspan="1">0.285, &lt;0.001</td><td rowspan="1" colspan="1">0.132, 0.050</td><td rowspan="1" colspan="1">0.193, 0.004</td></tr><tr><td rowspan="1" colspan="1">Mean SpO<sub>2</sub> (%)</td><td rowspan="1" colspan="1">−0.344, &lt;0.001</td><td rowspan="1" colspan="1">−0.304, &lt;0.001</td><td rowspan="1" colspan="1">−0.362, &lt;0.001</td><td rowspan="1" colspan="1">−0.303, &lt;0.001</td><td rowspan="1" colspan="1">−0.219, 0.001</td><td rowspan="1" colspan="1">−0.274, &lt;0.001</td></tr><tr><td rowspan="1" colspan="1">TS90 (%)</td><td rowspan="1" colspan="1">0.283, &lt;0.001</td><td rowspan="1" colspan="1">0.258, &lt;0.001</td><td rowspan="1" colspan="1">0.290, &lt;0.001</td><td rowspan="1" colspan="1">0.245, &lt;0.001</td><td rowspan="1" colspan="1">0.125, 0.064</td><td rowspan="1" colspan="1">0.175, 0.009</td></tr></tbody></table><table-wrap-foot><fn><p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Data are Spearman’s coefficients (rho, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> value).</citation_analysis></p></fn><fn><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> BMI, body mass index; AHI, apnea–hypopnea index; ODI, oxygen desaturation index; Mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, mean oxygen saturation; TS90, percentage of sleep duration with SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">&lt; 90%; RBC, red blood cell.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="S0003-S2003">
        <title>Association Between Nocturnal Hypoxemia and Polycythemia Among OSA Patients</title>
        <p><citation_analysis attribute="positive">Further, the difference between patients with OSA with and without polycythemia was compared, as shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="T0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="neither">. Patients with OSA with polycythemia were found to have higher AHI, ODI, and TS90, as well as lower mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">. In the subgroup analysis with similar AHI, the mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> was still significantly lower in patients with severe OSA and polycythemia compared with those without polycythemia (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001, </citation_analysis><citation_analysis attribute="positive"><xref rid="T0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="negative">). In the logistic regression analysis for the risk factors for polycythemia in men, mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, but not the AHI, was found to be an independent predictor of polycythemia (</citation_analysis><citation_analysis attribute="positive"><xref rid="T0005" ref-type="table">Table 5</xref></citation_analysis><citation_analysis attribute="positive">). We further conducted logistic regression analysis in men without smokers, which demonstrated that mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> was still independently associated with polycythemia–HGB (OR = 0.787; 95% CI: 0.645–0.961; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.018) after adjusting for age, BMI, and hypertension. On account of low polycythemia prevalence in women, the logistic regression analysis of rare events showed that the mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> was also independently associated with both polycythemia–HGB (OR = 0.848; 95% CI: 0.772–0.932; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) and polycythemia–HCT (OR = 0.847; 95% CI: 0.747–0.961; </citation_analysis><citation_analysis attribute="positive"><italic>P =</italic></citation_analysis><citation_analysis attribute="neither"> 0.010) in the female participants after adjustment for age, BMI, and hypertension.</citation_analysis><citation_analysis attribute="positive"><table-wrap id="T0004" orientation="landscape" position="float"><label>Table 4</label><caption><p><citation_analysis attribute="neither">Comparison of Clinical, Laboratory, and Polysomnographic Data in OSA Patients with or Without Polycythemia</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="3" rowspan="1">Total OSA</th><th colspan="3" rowspan="1">Severe OSA</th><th colspan="3" rowspan="1">Total OSA</th><th colspan="2" rowspan="1">Severe OSA</th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1">Variables</th><th rowspan="1" colspan="1">Without Polycythemia–HGB (n = 414)</th><th rowspan="1" colspan="1">With Polycythemia–HGB (n = 36)</th><th rowspan="1" colspan="1"><italic>P</italic> Value</th><th rowspan="1" colspan="1">Without Polycythemia–HGB (n = 223)</th><th rowspan="1" colspan="1">With Polycythemia–HGB (n = 29)</th><th rowspan="1" colspan="1"><italic>P</italic> Value</th><th rowspan="1" colspan="1">Without Polycythemia–HCT (n = 426)</th><th rowspan="1" colspan="1">With Polycythemia–HCT (n = 24)</th><th rowspan="1" colspan="1"><italic>P</italic> Value</th><th rowspan="1" colspan="1">Without Polycythemia–HCT (n = 229)</th><th rowspan="1" colspan="1">With Polycythemia–HCT (n = 23)</th><th rowspan="1" colspan="1"><italic>P</italic> Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (year)</td><td rowspan="1" colspan="1">31.62 ± 7.17</td><td rowspan="1" colspan="1">33.53 ± 5.98</td><td rowspan="1" colspan="1">0.123</td><td rowspan="1" colspan="1">34.07 ± 6.32</td><td rowspan="1" colspan="1">34.52 ± 6.05</td><td rowspan="1" colspan="1">0.717</td><td rowspan="1" colspan="1">31.65 ± 7.17</td><td rowspan="1" colspan="1">33.92 ± 5.31</td><td rowspan="1" colspan="1">0.057</td><td rowspan="1" colspan="1">34.12 ± 6.37</td><td rowspan="1" colspan="1">34.09 ± 5.36</td><td rowspan="1" colspan="1">0.980</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">32.45 ± 6.33</td><td rowspan="1" colspan="1">33.47 ± 6.85</td><td rowspan="1" colspan="1">0.356</td><td rowspan="1" colspan="1">31.89 ± 6.18</td><td rowspan="1" colspan="1">34.17 ± 7.10</td><td rowspan="1" colspan="1">0.068</td><td rowspan="1" colspan="1">32.39 ± 6.28</td><td rowspan="1" colspan="1">35.02 ± 7.44</td><td rowspan="1" colspan="1">0.049</td><td rowspan="1" colspan="1">31.88 ± 6.12</td><td rowspan="1" colspan="1">34.95 ± 7.59</td><td rowspan="1" colspan="1">0.072</td></tr><tr><td rowspan="1" colspan="1">AHI (events/h)</td><td rowspan="1" colspan="1">34.40 (13.38–66.53)</td><td rowspan="1" colspan="1">54.50 (36.45–76.38)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">64.70 (48.90–75.80)</td><td rowspan="1" colspan="1">65.00 (49.20–82.25)</td><td rowspan="1" colspan="1">0.660</td><td rowspan="1" colspan="1">34.40 (13.25–66.18)</td><td rowspan="1" colspan="1">65.15 (47.40–80.23)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">64.70 (48.60–75.95)</td><td rowspan="1" colspan="1">65.60 (50.70–81.10)</td><td rowspan="1" colspan="1">0.720</td></tr><tr><td rowspan="1" colspan="1">ODI (events/h)</td><td rowspan="1" colspan="1">42.40 (13.10–70.00)</td><td rowspan="1" colspan="1">53.40 (33.40–75.60)</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1">68.30 (51.70–81.35)</td><td rowspan="1" colspan="1">61.20 (49.00–81.88)</td><td rowspan="1" colspan="1">0.279</td><td rowspan="1" colspan="1">42.40 (13.30–69.13)</td><td rowspan="1" colspan="1">64.30 (49.00–81.98)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">66.85 (51.18–81.28)</td><td rowspan="1" colspan="1">64.80 (48.50–83.50)</td><td rowspan="1" colspan="1">0.761</td></tr><tr><td rowspan="1" colspan="1">Mean SpO<sub>2</sub> (%)</td><td rowspan="1" colspan="1">93.20 ± 4.15</td><td rowspan="1" colspan="1">87.48 ± 7.87</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">91.15 ± 4.45</td><td rowspan="1" colspan="1">86.64 ± 8.18</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">93.15 ± 4.25</td><td rowspan="1" colspan="1">85.83±7.70</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">91.12 ± 4.61</td><td rowspan="1" colspan="1">85.73 ± 7.87</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">TS90 (%)</td><td rowspan="1" colspan="1">6.60 (0.40–27.10)</td><td rowspan="1" colspan="1">29.45 (5.55–54.38)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">24.10 (9.20–42.98)</td><td rowspan="1" colspan="1">37.90 (18.55–58.55)</td><td rowspan="1" colspan="1">0.018</td><td rowspan="1" colspan="1">6.60 (0.50–27.10)</td><td rowspan="1" colspan="1">44.45 (21.74–63.08)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">24.05 (9.20–42.90)</td><td rowspan="1" colspan="1">47.30 (21.38–63.20)</td><td rowspan="1" colspan="1">0.006</td></tr><tr><td rowspan="1" colspan="1">RBC count (10<sup>3</sup>/uL)</td><td rowspan="1" colspan="1">4.84 ± 0.42</td><td rowspan="1" colspan="1">5.53 ± 0.47</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">4.92 ± 0.40</td><td rowspan="1" colspan="1">5.62 ± 0.39</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">4.85 ± 0.43</td><td rowspan="1" colspan="1">5.70 ± 0.39</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">4.93 ± 0.40</td><td rowspan="1" colspan="1">5.69 ± 0.40</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">HGB (g/L)</td><td rowspan="1" colspan="1">144.30 ± 12.28</td><td rowspan="1" colspan="1">170.58 ± 5.57</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">147.37 ± 11.64</td><td rowspan="1" colspan="1">171.34 ± 5.86</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">144.94 ± 12.67</td><td rowspan="1" colspan="1">172.42 ± 5.82</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">147.89 ± 11.91</td><td rowspan="1" colspan="1">172.48 ± 5.94</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">HCT (%)</td><td rowspan="1" colspan="1">42.65 ± 3.38</td><td rowspan="1" colspan="1">49.44 ± 3.72</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">43.50 ± 3.20</td><td rowspan="1" colspan="1">50.31 ± 2.69</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">42.74 ± 3.42</td><td rowspan="1" colspan="1">51.24 ± 2.26</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">43.59 ± 3.19</td><td rowspan="1" colspan="1">51.23 ± 2.31</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn><p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Data are presented as mean ± standard deviations or median with inter-quartile range if variables were not normally distributed.</citation_analysis></p></fn><fn><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> OSA, obstructive sleep apnea; BMI, body mass index; AHI, apnea–hypopnea index; ODI, oxygen desaturation index; Mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, mean oxygen saturation; TS90, percentage of sleep duration with SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">&lt; 90%; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><table-wrap id="T0005" orientation="portrait" position="float"><label>Table 5</label><caption><p><citation_analysis attribute="neither">Odds Ratio Estimates from Logistic Regression Analysis for the Risk Factors for Polycythemia in Men</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="3" rowspan="1">Men with Polycythemia–HGB</th><th colspan="3" rowspan="1">Men with Polycythemia–HCT</th></tr><tr><th rowspan="1" colspan="1">Independent Variables</th><th rowspan="1" colspan="1">Odds Ratio</th><th rowspan="1" colspan="1">95% Confidence Interval</th><th rowspan="1" colspan="1"><italic>P</italic> Value</th><th rowspan="1" colspan="1">Odd Ratio</th><th rowspan="1" colspan="1">95% Confidence Interval</th><th rowspan="1" colspan="1"><italic>P</italic> Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (year)</td><td rowspan="1" colspan="1">1.006</td><td rowspan="1" colspan="1">0.936–1.081</td><td rowspan="1" colspan="1">0.874</td><td rowspan="1" colspan="1">1.021</td><td rowspan="1" colspan="1">0.933–1.117</td><td rowspan="1" colspan="1">0.655</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">1.042</td><td rowspan="1" colspan="1">0.966–1.124</td><td rowspan="1" colspan="1">0.288</td><td rowspan="1" colspan="1">1.070</td><td rowspan="1" colspan="1">0.978–1.169</td><td rowspan="1" colspan="1">0.140</td></tr><tr><td rowspan="1" colspan="1">AHI (events/h)</td><td rowspan="1" colspan="1">1.018</td><td rowspan="1" colspan="1">0.982–1.056</td><td rowspan="1" colspan="1">0.325</td><td rowspan="1" colspan="1">1.015</td><td rowspan="1" colspan="1">0.972–1.060</td><td rowspan="1" colspan="1">0.491</td></tr><tr><td rowspan="1" colspan="1">ODI (events/h)</td><td rowspan="1" colspan="1">0.982</td><td rowspan="1" colspan="1">0.950–1.015</td><td rowspan="1" colspan="1">0.290</td><td rowspan="1" colspan="1">0.981</td><td rowspan="1" colspan="1">0.943–1.021</td><td rowspan="1" colspan="1">0.342</td></tr><tr><td rowspan="1" colspan="1">Mean SpO<sub>2</sub> (%)</td><td rowspan="1" colspan="1">0.802</td><td rowspan="1" colspan="1">0.689–0.934</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1">0.786</td><td rowspan="1" colspan="1">0.665–0.929</td><td rowspan="1" colspan="1">0.005</td></tr><tr><td rowspan="1" colspan="1">TS90 (%)</td><td rowspan="1" colspan="1">0.987</td><td rowspan="1" colspan="1">0.947–1.028</td><td rowspan="1" colspan="1">0.516</td><td rowspan="1" colspan="1">0.994</td><td rowspan="1" colspan="1">0.949–1.040</td><td rowspan="1" colspan="1">0.784</td></tr><tr><td rowspan="1" colspan="1">Smoking</td><td rowspan="1" colspan="1">0.426</td><td rowspan="1" colspan="1">0.177–1.025</td><td rowspan="1" colspan="1">0.057</td><td rowspan="1" colspan="1">0.420</td><td rowspan="1" colspan="1">0.148–1.197</td><td rowspan="1" colspan="1">0.104</td></tr><tr><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1">1.306</td><td rowspan="1" colspan="1">0.525–3.247</td><td rowspan="1" colspan="1">0.566</td><td rowspan="1" colspan="1">0.809</td><td rowspan="1" colspan="1">0.291–2.247</td><td rowspan="1" colspan="1">0.684</td></tr></tbody></table><table-wrap-foot><fn><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> BMI, body mass index; AHI, apnea–hypopnea index; ODI, oxygen desaturation index; Mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, mean oxygen saturation; TS90, percentage of sleep duration with SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">&lt; 90%; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
        <p><citation_analysis attribute="neither">Given that the mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> mainly affects the occurrence of polycythemia, the association between AHI and nocturnal hypoxia was also observed. The Spearman correlation analysis showed that the AHI significantly negatively correlated with mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> in both male (rho = –0.711, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) and female (rho = –0.465, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) participants. Furthermore, the mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> was significantly lower in both genders in the severe OSA group than in the control and the mild-to-moderate OSA groups (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001, </citation_analysis><citation_analysis attribute="positive"><xref rid="T0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">). Compared with the mild-to-moderate OSA group, the OR of polycythemia–HGB was 2.94 (95% CI: 1.10–7.85; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.025) and that of polycythemia–HCT was 12.11(95% CI: 1.61–91.08; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.002) in men in the severe OSA group, but not observed in women.</citation_analysis></p>
      </sec>
      <sec id="S0003-S2004">
        <title>Contribution of HBG and HCT in Assessing Nocturnal Hypoxemia Among OSA Patients</title>
        <p><citation_analysis attribute="neither">The ROC curve analysis was performed for the cutoff values of HBG and HCT to predict nocturnal hypoxemia defined with mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> &lt; 90% in OSA patients. The cutoff value of HGB was155.5 g/L in men, with a sensitivity of 60.9%, a specificity of 70.5%, and an AUC of 0.701 (95% CI: 0.628–0.775, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001; </citation_analysis><citation_analysis attribute="positive"><xref rid="F0001" ref-type="fig">Figure 1A</xref></citation_analysis><citation_analysis attribute="neither">); and 138.5 g/L in women, with a sensitivity of 60.0%, a specificity of 72.8%, and an AUC of 0.661 (95% CI: 0.498–0.824; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.045; </citation_analysis><citation_analysis attribute="positive"><xref rid="F0001" ref-type="fig">Figure 1B</xref></citation_analysis><citation_analysis attribute="neither">). The cutoff value of HCT was 44.6% in men, with a sensitivity of 82.8%, a specificity of 57.7%, and an AUC of 0.746 (95% CI: 0.675–0.817, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001; </citation_analysis><citation_analysis attribute="positive"><xref rid="F0001" ref-type="fig">Figure 1A</xref></citation_analysis><citation_analysis attribute="neither">); and 41.8% in women, with a sensitivity of 53.3%, a specificity of 84.5%, and an AUC of 0.677 (95% CI: 0.507–0.848, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.027; </citation_analysis><citation_analysis attribute="positive"><xref rid="F0001" ref-type="fig">Figure 1B</xref></citation_analysis><citation_analysis attribute="neither">). In addition, the AHI of ≥ 5 events/h was used to define OSA for the ROC analysis. The AUC for HGB to identify OSA was 0.574 (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.085) in men and 0.506 (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.882) in women; the AUC for HCT to identify OSA was 0.565 (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.127) in men and 0.539 (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.313) in women.</citation_analysis><citation_analysis attribute="positive"><fig id="F0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">ROC curves for HBG and HCT to predict nocturnal hypoxemia defined with as mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> &lt; 90% in patients with obstructive sleep apnea. (</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">) In men; (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="neither">) In women.</citation_analysis></p></caption><graphic content-type="print-only" xlink:href="NSS-11-377-g0001"/></fig></citation_analysis></p>
      </sec>
    </sec>
    <sec id="S0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="negative">To our best knowledge, this study was the first in analyzing a relatively large sample of young adults with untreated OSA to identify the relationship between OSA and polycythemia. Further, the differences in parameters among both genders was compared, and the cutoff points of HGB and HCT determining the nocturnal hypoxia risk of patients with OSA was calculated. This study yielded two key findings. First, nocturnal mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, but not the AHI, was an independent predictor of clinical polycythemia after adjusting for known important confounding variables, including age, sex, BMI, smoking, hypertension, and so on. Second, young male patients with OSA were more prone to suffer from polycythemia compared with female patients.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Several current hematologic guidelines recommend an OSA evaluation for the diagnosis of secondary polycythemia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="positive"> However, clinically significant polycythemia appears uncommon in those with OSA. Hoffstein et al reported 18 of 277 (6.5%) patients with OSA having HCT ≥ 50%;</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> Nguyen et al found 9.59% (119/1241) patients with OSA having HCT ≥ 48%;</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> and Solmaz et al detected only 1 of 335 patients with OSA having polycythemia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="positive"> The results were not consistent because of the different diagnostic criteria in previous studies, but the prevalence of polycythemia in OSA was low in general. In this study with young OSA subjects, 8.0% had polycythemia–HGB and 5.3% had polycythemia–HCT, consistent with the results of previous studies.</citation_analysis></p>
      <p><citation_analysis attribute="neither">In patients with OSA, airway collapse leads to CIH during sleep,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither"> contributing to decreased mean nocturnal hypoxia. The data of this study showed that the mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> decreased with the severity of OSA, and mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> in the severe OSA group was the lowest among the three groups. Sustained hypoxia, which is reflected by mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, leads to the activation of hypoxia-inducible factor-1 (HIF-1), resulting in an increased expression of erythropoietin (EPO) and polycythemia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="neither"> Previous animal studies</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="positive"> reported that CIH exposure could promote the generation of HIF-1 alpha and EPO, leading to significant increases in HGB and HCT. Meanwhile, Kang et al also showed that both CIH- and CCH-exposed rats had significantly higher HCT compared with those exposed to normoxia, but HCT in the CCH group was even much higher than that in the CIH group, which might be due to the longer duration and heavier intensity of hypoxia in CCH.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="positive"> Hypoxic effects on HBG and HCT are heavily dependent on the duration and intensity of the hypoxic stimulus.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="positive"> Similarly, Winnicki et al reported that EPO increased only in patients with severe OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="positive"> In this study, although the RBC counts, HBG, and HCT increased with the severity of OSA, only the severe OSA group had significantly higher RBC counts, HBG, and HCT compared with the control group; this result was consistent with that in the study by Solmaz et al.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0017" ref-type="bibr">17</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">OSA is a heterogeneous disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> In the subgroup analysis with a similar AHI, patients with polycythemia had significantly lower nocturnal mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> compared with those without polycythemia. Although the AHI significantly correlated with mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> in both genders, mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, but not the AHI, was determined as an independent predictor of polycythemia. As expected, according to the ROC analysis in this study, the AUC of HBG and HCT in detecting mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> &lt; 90% was more than that in detecting the AHI. These results indicated that nocturnal hypoxemia was a stronger predictor of polycythemia compared with OSA severity.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> It was assumed that OSA led to polycythemia, which mainly depended on the intensity, frequency, and duration of intermittent hypoxia cycles.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="neither"> This might explain why most prior cohort studies</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="positive"> generally failed to demonstrate a clear association between untreated OSA (measured by the AHI) and polycythemia. However, in view of the close relationship between AHI and mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, OSA evaluation may still be warranted in those with unexplained polycythemia.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> Additionally, the cutoff value for HGB and HCT was155.5g/L and 44.6%, respectively, for assessing nocturnal hypoxemia in male OSA patients, demonstrating moderate accuracy. This was the first report on the cutoff value of hematological indices in young adults with OSA,</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="positive"> and it was suggested that erythrocytic parameters might serve as useful tools for screening nocturnal hypoxia severity of OSA patients.</citation_analysis></p>
      <p><citation_analysis attribute="neither">In this study, differences in RBC count, HGB, and HCT were found between men and women. Although nocturnal mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="positive"> independently negatively correlated with RBC count, HGB, and HCT in both genders, the correlation coefficients were weaker in women. Moreover, OSA rarely led to polycythemia in female patients, which was consistent with the results of a previous study.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> OSA is more common in male patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither"> It was revealed that mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> was significantly lower in men compared with women. Men showed higher HGB and HCT levels compared with women because of higher testosterone levels, which facilitate erythropoiesis, and genetic differences in the EPO gene.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> 17β-estradiol can also influence the expression of hypoxia-inducible genes and decrease hypoxic induction of the expression of the EPO gene.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> Further, female resilience to CIH-induced upper airway muscle dysfunction existed during acute exposure to severe hypoxic stress, but male patients had a greater loss of muscle performance.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, exposure to hypoxic significantly increased the hypoxic ventilatory response in women than in men.</citation_analysis><citation_analysis attribute="positive"><xref rid="CIT0038" ref-type="bibr">38</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">This study had several limitations. First, given the cross-sectional nature of this single-center study, inferences on the cause-and-effect sequence between nocturnal mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> and polycythemia were not possible. Second, the changes in RBC count, HGB, and HCT pre-CPAP and after-CPAP treatment were not investigated. Third, this study was a preliminary research work on young adults without further exploration of fundamental mechanisms. Moreover, further prospective studies are needed to explore the impact of OSA and nocturnal hypoxia on the polycythemia.</citation_analysis></p>
    </sec>
    <sec id="S0005">
      <title>Conclusion</title>
      <p><citation_analysis attribute="neither">In summary, compared with the AHI, nocturnal mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> proved to be an independent predictor of polycythemia in young adults. Men were more prone to suffer from polycythemia compared with women. Hematological parameters, such as HGB and HCT, may have diagnostic utility for assessing nocturnal hypoxia severity of patients with OSA, especially in men.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">This study was supported by grants from the National Key Technology Research and Development Program of China (2018YFC1311900), the National Nature Science Foundation of China (81770084 and 81570082) and the Shanghai Key Discipline for Respiratory Disease (2017ZZ02014).</citation_analysis></p>
    </ack>
    <sec id="S0006" sec-type="COI-statement">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors declare no conflicts of interest in this study.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Benjafield</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Ayas</surname>
<given-names>NT</given-names></string-name>, <string-name><surname>Eastwood</surname>
<given-names>PR</given-names></string-name>, et al. <article-title>Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis</article-title>. <source><italic toggle="yes">Lancet Respir Med</italic></source>. <year>2019</year>;<volume>7</volume>(<issue>8</issue>):<fpage>687</fpage>–<lpage>698</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2213-2600(19)30198-5</pub-id><pub-id pub-id-type="pmid">31300334</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gordeuk</surname>
<given-names>VR</given-names></string-name>, <string-name><surname>Key</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Prchal</surname>
<given-names>JT</given-names></string-name>. <article-title>Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis</article-title>. <source><italic toggle="yes">Haematologica</italic></source>. <year>2019</year>;<volume>104</volume>(<issue>4</issue>):<fpage>653</fpage>–<lpage>658</lpage>. doi:<pub-id pub-id-type="doi">10.3324/haematol.2018.210732</pub-id><pub-id pub-id-type="pmid">30872370</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>McMullin</surname>
<given-names>MF</given-names></string-name>. <article-title>Investigation and management of erythrocytosis</article-title>. <source><italic toggle="yes">Curr Hematol Malig Rep</italic></source>. <year>2016</year>;<volume>11</volume>(<issue>5</issue>):<fpage>342</fpage>–<lpage>347</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11899-016-0334-1</pub-id><pub-id pub-id-type="pmid">27423232</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jordan</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>McSharry</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Malhotra</surname>
<given-names>A</given-names></string-name>. <article-title>Adult obstructive sleep apnoea</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2014</year>;<volume>383</volume>(<issue>9918</issue>):<fpage>736</fpage>–<lpage>747</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(13)60734-5</pub-id><pub-id pub-id-type="pmid">23910433</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>XB</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>HQ</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>HP</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>HL</given-names></string-name>. <article-title>Erythropoietin levels in patients with sleep apnea: a meta-analysis</article-title>. <source><italic toggle="yes">Eur Arch Otorhinolaryngol</italic></source>. <year>2017</year>;<volume>274</volume>(<issue>6</issue>):<fpage>2505</fpage>–<lpage>2512</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00405-017-4483-1</pub-id><pub-id pub-id-type="pmid">28280920</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Long</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>. <article-title>The association of hemocyte profile and obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Clin Lab Anal</italic></source>. <year>2019</year>;<volume>33</volume>(<issue>2</issue>):<fpage>e22680</fpage>. doi:<pub-id pub-id-type="doi">10.1002/jcla.2019.33.issue-2</pub-id><pub-id pub-id-type="pmid">30246267</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>H</given-names></string-name>. <article-title>Hematological indices as simple, inexpensive and practical severity markers of obstructive sleep apnea syndrome: a meta-analysis</article-title>. <source><italic toggle="yes">J Thorac Dis</italic></source>. <year>2018</year>;<volume>10</volume>(<issue>12</issue>):<fpage>6509</fpage>–<lpage>6521</lpage>. doi:<pub-id pub-id-type="doi">10.21037/jtd</pub-id><pub-id pub-id-type="pmid">30746195</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>JX</given-names></string-name>, <string-name><surname>Lü</surname>
<given-names>XT</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>BY</given-names></string-name>. <article-title>Effects of intermittent hypoxic exposure on the parameter of erythrocyte and serum hypoxia inducible factor-1 alpha and erythropoietin levels</article-title>. <source><italic toggle="yes">Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi</italic></source>. <year>2009</year>;<volume>25</volume>(<issue>10</issue>):<fpage>932</fpage>–<lpage>934</lpage>.<pub-id pub-id-type="pmid">20104680</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ishii</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Iwamoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nagai</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sasao</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Iwasaki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kuwahira</surname>
<given-names>I</given-names></string-name>. <article-title>Polycythemia and changes in erythropoietin concentration in rats exposed to intermittent hypoxia</article-title>. <source><italic toggle="yes">Adv Exp Med Biol</italic></source>. <year>2010</year>;<volume>662</volume>:<fpage>121</fpage>–<lpage>126</lpage>.<pub-id pub-id-type="pmid">20204781</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Alvarez-Martins</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Remédio</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Matias</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Diogo</surname>
<given-names>LN</given-names></string-name>, <string-name><surname>Monteiro</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Dias</surname>
<given-names>S</given-names></string-name>. <article-title>The impact of chronic intermittent hypoxia on hematopoiesis and the bone marrow microenvironment</article-title>. <source><italic toggle="yes">Pflugers Arch</italic></source>. <year>2016</year>;<volume>468</volume>(<issue>5</issue>):<fpage>919</fpage>–<lpage>932</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00424-016-1797-6</pub-id><pub-id pub-id-type="pmid">26856724</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Feliciano</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Linhas</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Marçôa</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Hematological evaluation in males with obstructive sleep apnea before and after positive airway pressure</article-title>. <source><italic toggle="yes">Rev Port Pneumol (2006)</italic></source>. <year>2017</year>;<volume>23</volume>(<issue>2</issue>):<fpage>71</fpage>–<lpage>78</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.rppnen.2016.12.001</pub-id><pub-id pub-id-type="pmid">28153627</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Pathak</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Giri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Karmacharya</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Aryal</surname>
<given-names>MR</given-names></string-name>. <article-title>Obstructive sleep apnea syndrome and secondary polycythemia: analysis of the nationwide inpatient sample</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2015</year>;<volume>16</volume>(<issue>1</issue>):<fpage>205</fpage>–<lpage>206</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2014.09.012</pub-id><pub-id pub-id-type="pmid">25534581</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><collab>BSH Committee</collab>, <string-name><surname>McMullin</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Harrison</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Ali</surname>
<given-names>S</given-names></string-name>, et al. <article-title>A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline</article-title>. <source><italic toggle="yes">Br J Haematol</italic></source>. <year>2019</year>;<volume>184</volume>(<issue>2</issue>):<fpage>176</fpage>–<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bjh.2019.184.issue-2</pub-id><pub-id pub-id-type="pmid">30478826</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hoffstein</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Herridge</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mateika</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Redline</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Strohl</surname>
<given-names>KP</given-names></string-name>. <article-title>Hematocrit levels in sleep apnea</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>1994</year>;<volume>106</volume>(<issue>3</issue>):<fpage>787</fpage>–<lpage>791</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.106.3.787</pub-id><pub-id pub-id-type="pmid">8082360</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Choi</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Loredo</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Norman</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Does obstructive sleep apnea increase hematocrit?</article-title>
<source><italic toggle="yes">Sleep Breath</italic></source>. <year>2006</year>;<volume>10</volume>(<issue>3</issue>):<fpage>155</fpage>–<lpage>160</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-006-0064-z</pub-id><pub-id pub-id-type="pmid">16770648</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>King</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Eyre</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Littlewood</surname>
<given-names>T</given-names></string-name>. <article-title>Obstructive sleep apnoea does not lead to clinically significant erythrocytosis</article-title>. <source><italic toggle="yes">BMJ</italic></source>. <year>2013</year>;<volume>347</volume>:<fpage>f7340</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.f7340</pub-id><pub-id pub-id-type="pmid">24322178</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Solmaz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Duksal</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ganidağlı</surname>
<given-names>S</given-names></string-name>. <article-title>Is obstructive sleep apnoea syndrome really one of the causes of secondary polycythaemia?</article-title>
<source><italic toggle="yes">Hematology</italic></source>. <year>2015</year>;<volume>20</volume>(<issue>2</issue>):<fpage>108</fpage>–<lpage>111</lpage>. doi:<pub-id pub-id-type="doi">10.1179/1607845414Y.0000000170</pub-id><pub-id pub-id-type="pmid">24801394</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nguyen</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Holty</surname>
<given-names>JC</given-names></string-name>. <article-title>Does untreated obstructive sleep apnea cause secondary erythrocytosis?</article-title>
<source><italic toggle="yes">Respir Med</italic></source>. <year>2017</year>;<volume>130</volume>:<fpage>27</fpage>–<lpage>34</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.rmed.2017.07.003</pub-id><pub-id pub-id-type="pmid">29206630</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mandala</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Gondwe</surname>
<given-names>EN</given-names></string-name>, <string-name><surname>MacLennan</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Molyneux</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>MacLennan</surname>
<given-names>CA</given-names></string-name>. <article-title>Age- and sex-related changes in hematological parameters in healthy Malawians</article-title>. <source><italic toggle="yes">J Blood Med</italic></source>. <year>2017</year>;<volume>8</volume>:<fpage>123</fpage>–<lpage>130</lpage>. doi:<pub-id pub-id-type="doi">10.2147/JBM.S142189</pub-id><pub-id pub-id-type="pmid">28919829</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Complete blood count reference intervals for healthy Han Chinese adults</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2015</year>;<volume>10</volume>(<issue>3</issue>):<fpage>e0119669</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0119669</pub-id><pub-id pub-id-type="pmid">25769040</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Adeli</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Raizman</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Complex biological profile of hematologic markers across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey</article-title>. <source><italic toggle="yes">Clin Chem</italic></source>. <year>2015</year>;<volume>61</volume>(<issue>8</issue>):<fpage>1075</fpage>–<lpage>1086</lpage>. doi:<pub-id pub-id-type="doi">10.1373/clinchem.2015.240531</pub-id><pub-id pub-id-type="pmid">26044509</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cristancho</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Riveros</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sánchez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Peñuela</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Böning</surname>
<given-names>D</given-names></string-name>. <article-title>Diurnal changes of arterial oxygen saturation and erythropoietin concentration in male and female highlanders</article-title>. <source><italic toggle="yes">Physiol Rep</italic></source>. <year>2016</year>;<volume>4</volume>(<issue>17</issue>):<fpage>e12901</fpage>. doi:<pub-id pub-id-type="doi">10.14814/phy2.12901</pub-id><pub-id pub-id-type="pmid">27597764</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Malenica</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Prnjavorac</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Bego</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Effect of cigarette smoking on haematological parameters in healthy population</article-title>. <source><italic toggle="yes">Med Arch</italic></source>. <year>2017</year>;<volume>71</volume>(<issue>2</issue>):<fpage>132</fpage>–<lpage>136</lpage>. doi:<pub-id pub-id-type="doi">10.5455/medarh</pub-id>.<pub-id pub-id-type="pmid">28790546</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Soranzo</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Spector</surname>
<given-names>TD</given-names></string-name>, <string-name><surname>Mangino</surname>
<given-names>M</given-names></string-name>, et al. <article-title>A genome-wide meta-analysis identifies 22 loci associated with eighthematological parameters in the HaemGen consortium</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2009</year>;<volume>41</volume>(<issue>11</issue>):<fpage>1182</fpage>–<lpage>1190</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.467</pub-id><pub-id pub-id-type="pmid">19820697</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Grau</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cremer</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Schmeichel</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kunkel</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bloch</surname>
<given-names>W</given-names></string-name>. <article-title>Comparisons of blood parameters, red blood cell deformability and circulating nitric oxide between males and females considering hormonal contraception: a longitudinal gender study</article-title>. <source><italic toggle="yes">Front Physiol</italic></source>. <year>2018</year>;<volume>9</volume>:<fpage>1835</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2018.01835</pub-id><pub-id pub-id-type="pmid">30618840</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Maggio</surname>
<given-names>M</given-names></string-name>, <string-name><surname>De Vita</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Fisichella</surname>
<given-names>A</given-names></string-name>, et al. <article-title>The role of the multiple hormonal dysregulation in the onset of “anemia of aging”: focus on testosterone, IGF-1, and thyroid hormones</article-title>. <source><italic toggle="yes">Int J Endocrinol</italic></source>. <year>2015</year>;<volume>2015</volume>:<fpage>292574</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2015/292574</pub-id><pub-id pub-id-type="pmid">26779261</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Erdim</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Oghan</surname>
<given-names>F</given-names></string-name>. <article-title>Blood count values and ratios for predicting sleep apnea in obese children</article-title>. <source><italic toggle="yes">Int J Pediatr Otorhinolaryngol</italic></source>. <year>2017</year>;<volume>99</volume>:<fpage>157</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijporl.2017.06.027</pub-id><pub-id pub-id-type="pmid">28662848</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Palma</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Iriarte</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fernandez</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Characterizing the phenotypes of obstructive sleep apnea: clinical, sleep, and autonomic features of obstructive sleep apnea with and without hypoxia</article-title>. <source><italic toggle="yes">Clin Neurophysiol</italic></source>. <year>2014</year>;<volume>125</volume>(<issue>9</issue>):<fpage>1783</fpage>–<lpage>1791</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clinph.2014.01.029</pub-id><pub-id pub-id-type="pmid">24631013</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yilmaz Avci</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Avci</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lakadamyali</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Can</surname>
<given-names>U</given-names></string-name>. <article-title>Hypoxia and inflammation indicate significant differences in the severity of obstructive sleep apnea within similar apnea-hypopnea index groups</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2017</year>;<volume>21</volume>(<issue>3</issue>):<fpage>703</fpage>–<lpage>711</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-017-1486-5</pub-id><pub-id pub-id-type="pmid">28271327</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Whelton</surname>
<given-names>PK</given-names></string-name>, <string-name><surname>Carey</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Aronow</surname>
<given-names>WS</given-names></string-name>, et al. <article-title>2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines</article-title>. <source><italic toggle="yes">Hypertension</italic></source>. <year>2018</year>;<volume>71</volume>(<issue>6</issue>). <fpage>e13</fpage>–<lpage>e115</lpage>.<pub-id pub-id-type="pmid">29133356</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0031">
        <label>31.</label>
        <mixed-citation publication-type="book"><string-name><surname>Berry</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Brooks</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gamaldo</surname>
<given-names>CE</given-names></string-name>; <collab>American Academy of Sleep Medicine</collab>, et al. <source><italic toggle="yes">The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Version 2.3</italic></source>. <publisher-loc>Darien, IL</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>;<year>2016</year>.</mixed-citation>
      </ref>
      <ref id="CIT0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Arcasoy</surname>
<given-names>MO</given-names></string-name>. <article-title>The clinical and laboratory evaluation of the patient with erythrocytosis</article-title>. <source><italic toggle="yes">Eur J Intern Med</italic></source>. <year>2015</year>;<volume>26</volume>(<issue>5</issue>):<fpage>297</fpage>–<lpage>302</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejim.2015.03.007</pub-id><pub-id pub-id-type="pmid">25837692</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Song</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sundar</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Gangaraju</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Prchal</surname>
<given-names>JT</given-names></string-name>. <article-title>Regulation of erythropoiesis after normoxic return from chronic sustained and intermittent hypoxia</article-title>. <source><italic toggle="yes">J Appl Physiol (1985)</italic></source>. <year>2017</year>;<volume>123</volume>(<issue>6</issue>):<fpage>1671</fpage>–<lpage>1675</lpage>. doi:<pub-id pub-id-type="doi">10.1152/japplphysiol.00119.2017</pub-id><pub-id pub-id-type="pmid">28522758</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Chronic intermittent hypoxia versus continuous hypoxia: same effects on hemorheology?</article-title>
<source><italic toggle="yes">Clin Hemorheol Microcirc</italic></source>. <year>2016</year>;<volume>63</volume>(<issue>3</issue>):<fpage>245</fpage>–<lpage>255</lpage>. doi:<pub-id pub-id-type="doi">10.3233/CH-151973</pub-id><pub-id pub-id-type="pmid">26444604</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Winnicki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shamsuzzaman</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lanfranchi</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Erythropoietin and obstructive sleep apnea</article-title>. <source><italic toggle="yes">Am J Hypertens</italic></source>. <year>2004</year>;<volume>17</volume>(<issue>9</issue>):<fpage>783</fpage>–<lpage>786</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.amjhyper.2004.04.011</pub-id><pub-id pub-id-type="pmid">15363820</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wimms</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Woehrle</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ketheeswaran</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ramanan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Armitstead</surname>
<given-names>J</given-names></string-name>. <article-title>Obstructive sleep apnea in women: specific issues and interventions</article-title>. <source><italic toggle="yes">Biomed Res Int</italic></source>. <year>2016</year>;<volume>2016</volume>:<fpage>1764837</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2016/1764837</pub-id><pub-id pub-id-type="pmid">27699167</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>O’Halloran</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>P</given-names></string-name>, <string-name><surname>McDonald</surname>
<given-names>F</given-names></string-name>. <article-title>Sex, stress and sleep apnoea: decreased susceptibility to upper airway muscle dysfunction following intermittent hypoxia in females</article-title>. <source><italic toggle="yes">Respir Physiol Neurobiol</italic></source>. <year>2017</year>;<volume>245</volume>:<fpage>76</fpage>–<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.resp.2016.11.009</pub-id><pub-id pub-id-type="pmid">27884793</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Soliz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Thomsen</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Soulage</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lundby</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gassmann</surname>
<given-names>M</given-names></string-name>. <article-title>Sex-dependent regulation of hypoxic ventilation in mice and humansis mediated by erythropoietin</article-title>. <source><italic toggle="yes">Am J Physiol Regul Integr Comp Physiol</italic></source>. <year>2009</year>;<volume>296</volume>(<issue>6</issue>):<fpage>R1837</fpage>–<lpage>R1846</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpregu.90967.2008</pub-id><pub-id pub-id-type="pmid">19321698</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
